Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre.

Published in:

BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10857-8

By:

• Lau, David K.;
• Fong, Caroline;
• Arouri, Faten;
• Cortez, Lillian;
• Katifi, Hannah;
• Gonzalez-Exposito, Reyes;
• Razzaq, Muhammad Bilal;
• Li, Su;
• Macklin-Doherty, Aislinn;
• Hernandez, Monica Arenas;
• Hubank, Michael;
• Fribbens, Charlotte;
• Watkins, David;
• Rao, Sheela;
• Chau, Ian;
• Cunningham, David;
• Starling, Naureen

Publication type:

Article